Suggestions

Du même auteur

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients

Archive ouverte | El-Deiry, Wafik, S | CCSD

International audience. WIN's MTB leadership is constituted by both precision oncology and disease experts to guide the discussion.

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Archive ouverte | Rodon, Jordi | CCSD

International audience

Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer

Archive ouverte | Li, Bob | CCSD

International audience. PURPOSE HER2 exon 20 insertions and point mutations are oncogenic drivers found in 1%-2% of patients with non–small-cell lung cancer (NSCLC). No targeted therapy is approved for this subset o...

Chargement des enrichissements...